Search clinical trials for: cediranib
Total 108 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone Refractory Prostate CancerUnited States, Canada
-
University Health Network, TorontoAstraZenecaCompletedOvarian CancerCanada
-
National Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous MesotheliomaUnited States
-
National Cancer Institute (NCI)TerminatedNeurofibromatosis Type 1 | Plexiform Neurofibroma | Spinal Cord NeurofibromaUnited States
-
University College, LondonAstraZenecaTerminatedGlioblastomaUnited Kingdom
-
AstraZenecaCompletedColorectal CancerVietnam, United States, Australia, Czech Republic, France, Italy, Poland, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Philippines, Germany, Hungary, Latvia, Ukraine, Finland, Austria, Belgium, Canada, Israel, Sl... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsUnited States
-
AstraZenecaCompletedRenal Cell CarcinomaUnited Kingdom, Netherlands
-
AstraZenecaCompletedMetastatic Colorectal CancerBrazil, Bulgaria, Czech Republic, Korea, Republic of, Poland, United Kingdom, Philippines, China, Germany, Hungary, Argentina, Taiwan, Switzerland, Australia, India
-
AstraZenecaCompletedRecurrent GlioblastomaUnited States, Australia, France, United Kingdom, Germany, Netherlands, Canada, Austria, Belgium, Czech Republic
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
AstraZenecaCompletedAdvanced Breast CancerUnited States, Australia, Brazil
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Childhood Grade I Meningioma | Childhood Grade II Meningioma | Childhood Grade III Meningioma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerCanada
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Epithelial Cancer | Stage I Ovarian Epithelial Cancer | Stage II Ovarian Epithelial CancerUnited States
-
Medical Research CouncilNational Health and Medical Research Council, Australia; AstraZeneca; Cancer... and other collaboratorsUnknownOvarian CancerUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Ovarian Carcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Recurrent Non-Small Cell... and other conditionsCanada
-
University College, LondonAstraZenecaCompletedBiliary Tract NeoplasmsUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Localized Malignant MesotheliomaUnited States
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark
-
National Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
AstraZenecaCompletedMetastatic Colorectal CancerJapan
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
AstraZenecaCompletedCarcinoma | Head and Neck Neoplasms | Non-Small-Cell Lung CarcinomaUnited States, Spain
-
University of GlasgowCompleted
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Radboud University Medical CenterTerminatedCediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural EffusionMalignant Ascites | Malignant Pleural EffusionNetherlands
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Renal Cell Cancer | Stage IV Non-small Cell Lung Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer | Tumors Metastatic to BrainUnited States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedColorectal CancerCzech Republic, France, Italy, Spain, United Kingdom, Germany, Canada, Austria, Belgium
-
AstraZenecaCompletedTumorsNetherlands, Germany, United Kingdom
-
AstraZenecaCompletedGastrointestinal Stromal Tumors | Soft Tissue SarcomasUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid TumorUnited States
-
AstraZenecaRoyal Marsden NHS Foundation TrustCompleted
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
AstraZenecaCompleted
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungJapan
-
AstraZenecaCompletedAdvanced Solid TumorsDenmark, Canada